A Greater Variability in the 3′ Flanking Region of the IL-6 Gene in Patients with Systemic Lupus Erythematosus (SLE)

References

• Cairns E. J., Germain St. J., Bell D. The in vitro production of anti‐DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE patients. J. Immunology. 1985; 135: 3839–3844
   PubMedGoogle Scholar
• Janel R. C., George J. L., Silberstein D. S., Eaton R. B., Schur P. H. The effect of adherent cell‐derived factors on immunoglobulin and anti‐DNA synthesis in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1987; 42: 344–349
   Google Scholar
• Linker‐Israeli M., Quismorio F. P., Jr., Honvitz D. A. CD8 + lymphocytes from patients with SLE sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support auto‐antibody synthesis. Arthritis Rheum. 1990; 33: 1216–1215
   PubMedGoogle Scholar
• Kitani A., Hara M., Hirose T., Harigai M., Suzuki K., Kawakami M., et al. Autostimulatory effects of IL‐6 on excessive B cell differentiation in patients with SLE: analysis of IL‐6 production and IL6R expression. Clin. Exp. Immunol. 1992; 88: 75–83
   PubMed Web of Science ®Google Scholar
• Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of Interleukin‐6. Immunology Today. 1990; 11: 199–206
   Google Scholar
• Van Snick J. Interleukin‐6: an overview. Annu. Rev. Immunol. 1990; 11: 199–204
   Google Scholar
• Yasukawa K., Hirano T., Watanabe T., Murashima M., Matsuda S., Nakai, et al. Structure and expression of human BSF‐2/IL6 gene. The EMBO J. 1987; 6: 2939–2944
   PubMed Web of Science ®Google Scholar
• Horii Y., Muraguchi A., Iwano M., Matsuda T., Hirayama T., Yamada H., et al. Involvement of IL‐6 in mesangial proliferative glomerulonephritis. J. Immunol. 1989; 143: 3949–3955
   PubMed Web of Science ®Google Scholar
• Grossman R. M., Kreuger J., Yourish D., Granelli‐Piperno A., Murphy P. D., May L. T., et al. IL‐6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci USA. 1989; 86: 6367–6371
   PubMed Web of Science ®Google Scholar
• Guerne P. A., Zuraw B. L., Vaughan J. H., Carson D. A., Lotz M. Synovium as a source of Interleukin‐6 in vitro: contribution to local and systemic manifestations of arthritis. J. Clin. Invest. 1989; 83: 585–592
   PubMed Web of Science ®Google Scholar
• Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., et al. Pathogenic significance of interleukin‐6 (IL‐6/BSF‐2) in Castleman's disease. Blood. 1989; 74: 1360
   PubMed Web of Science ®Google Scholar
• Breen E., Rezai A. R., Nakajima K., Beall G. N., Mitsuyasu R. T., Hiro T., et al. Infection with HIV is associated with elevated IL‐6 levels and production. J. Immunol. 1990; 144: 480–484
   PubMed Web of Science ®Google Scholar
• Deviere J., Content J., Denys C., Vanderbussche P., Schandene L., Wybren J. High IL‐6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis: correlation with IgA serum levels and lymphokine production. Clin. Exp. Immunol. 1989; 77: 221–227
   PubMed Web of Science ®Google Scholar
• Hirano T., Taga T., Yasukawa K., Nakajima K., Nakano N., Takatsuki F., et al. Human B cell differentiation factor defined by an antipeptide antibody and its possible role in autoantibody production. Proc. Natl. Acad. Sci. 1987; 84: 228–231
   PubMed Web of Science ®Google Scholar
• Linker‐Israeli M., Deans R. J. Dysregulated lymphokine production in SLE. Ann. NY Acad. Sci. 1988; 557: 567–573
   Google Scholar
• Linker‐Israeli M., Deans R. J., Wallace D. J., Prehn J., Ozeri Chen T., Klinenberg J. Elevated levels of endogenous IL‐6: a putative role in pathogenesis. J. Immunol. 1991; 147: 117–123
   PubMed Web of Science ®Google Scholar
• Teppo A. M., Metsarime K., Fythrquist F. Radioimmunoassay of IL‐6 in plasma. Clin. Chem. 1991; 37: 1691–1695
   PubMed Web of Science ®Google Scholar
• Pelton B. K., Hylton W., Denman A. M. Activation of IL‐6 production by UV irradiation of blood mononuclear cells from patients with SLE. Clin. Exp. Immunol. 1992; 89: 251–254
   Google Scholar
• Finck B. K., Chan B., Wofsy D. IL‐6 promotes murine lupus in NZB/NZW F1 mice. J. Clin. Invest. 1994; 94: 585–591
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum. 1982; 25: 1271–1276
   PubMed Web of Science ®Google Scholar
• Liang M. H., Socher S. A., Larson M. G., Schur P. H. Reliability and validity of six systems for the clinical assessment of disease activity in SLE. Arthritis Rheum. 1989; 32: 1107–1118
   PubMed Web of Science ®Google Scholar
• Sambrook J. E., Fritsch F., Maniatis T. Ch 7. Molecular Cloning: A laboratory manual. 1989; 7–13
   Google Scholar
• Hirano T., Yasukawa K., Harada H., Taga T., Watanabe T., Matsuda S., et al. Complementary DNA for a novel human interleukin (BSF‐2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73–76
   PubMed Web of Science ®Google Scholar
• Auron P. E., Webb C., Rosenwasser L. J., Mucci S. F., Rich A., et al. Nucleotide sequence of human monocyte ILI precursor cDNA. Proc. Natl. Acad. Sci. 1984; 81: 7907–7911
   PubMed Web of Science ®Google Scholar
• Gunning P., Ponte P., Okayama H., Engel J., Blau H., Kedesz L. Isolation and characterization of full length cDNA clones for human alpha‐beta‐gamma ac‐tin mRNAs: skeletal but not cytoplasmic actins have an amino terminal cysteine that is subsequently removed. Mol. Cell. Biol. 1983; 3: 787–795
   PubMed Web of Science ®Google Scholar
• Feinberg A. P., Vogelstein B. A technique for labelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1983; 132: 6–10
   PubMed Web of Science ®Google Scholar
• Bowcock A. M., Ray A., Erlich H., Sehgal P. B. Rapid detection and sequencing of alleles in the 3′ flanking region of the IL6 gene. Nucleic Acids Research. 1989; 17: 6855–6864
   Google Scholar
• Bowcock A. M., Kidd J. R., Lathrop G. M., Daneshvar L., May L. T., Ray A., et al. The human “Interferon‐b2/Hepatocyte Stimulating Factor/IL‐6” gene: DNA Polymorphism studies and localization to chromosome 7p21. Genomics. 1988; 3: 8–16
   PubMedGoogle Scholar
• Boulikas T. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell. Biochem. 1993; 52: 14–22
   PubMedGoogle Scholar
• Arnett F. C. The genetic basis of lupus erythematosus. Dubois' Lupus Erythematosus4th ed., D. J. Wallace, B. H. Hahn. Lea & Febiger. 1993; 13–36
   Google Scholar
• Block S. R., Winfield J. B., Lockshin M. D., D'Angel W. A., Christian L. C. Studies with twins with SLE. A review of the literature and presentation of 12 additional cases. Amer. J. Med. 1975; 59: 532–552
   Google Scholar
• Wilson D. W., Scopetelis E., Michalski J. P. Association of susceptibility to SLE in Caucasian and Black Americans. J. Rheum. 1986; 11: 653–657
   Google Scholar
• Fronek Z., Timmerman L. A., Alper C. A., Hahn B. H., Kalunian K., Peterlin M. B., et al. MHC complex genes and susceptibility to SLE. Arthritis Rheum. 1990; 33: 1542–1553
   PubMed Web of Science ®Google Scholar
• Winchester R. J. Genetic aspects in the clinical management of SLE, P. H. Schur. Grune and Stratton. 1983; 17–29
   Google Scholar
• Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O. Heritable major histocompatibility complex class‐II associated differences in production of tumor necrosis factor‐alpha; relevance to genetic predisposition to SLE. Proc. Natl. Acad. Sci. USA. 1990; 87: 1233–1237
   PubMed Web of Science ®Google Scholar
• Frank M. B., McArthur R., Harley J. B., Fujisaku A. Anti Ro (SSA) autoantibodies are associated with T‐cell receptor beta genes in SLE patients. J. Clin. Invest. 1990; 85: 33–39
   PubMed Web of Science ®Google Scholar
• Tebib J. G., Alcocer‐Varela J., Alarcon‐Segovia D., Schur P. Association between a T cell receptor restriction fragment length polymorphism and SLE. J. Clin. Invest. 1990; 86: 1961–1967
   PubMed Web of Science ®Google Scholar
• Clark M., Liu L., Clarkson S. B., Ory P. A., Goldstein I. M. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with SLE. J. Clin. Invest. 1990; 86: 341–346
   PubMed Web of Science ®Google Scholar
• Tomita Y., Hashimoto S., Yamagami K., Sawada S., Horie T. RFLP analysis in the TNF genes of patients with SLE. Clin. Exp. Rheum. 1992; 11(5)533–536
   Google Scholar
• Fugger L., Morling N., Sandberg‐Wollheim M., Ryder L. P., Svejgaard A. TNF‐alpha gene polymorphism in MS and optic neuritis. J. Neuroimmunol. 1990; 27(1)85–88
   Google Scholar
• Bailly S., di Giovinne F. S., Blakemore A. I., Duff G. W. Genetic polymorphism of human IL‐1 alpha. Eur. J. Immunol. 1993; 23(6)1240–1245
   Google Scholar